Skip to main content
Journal cover image

Off-label applications for SSRIs.

Publication ,  Journal Article
Stone, KJ; Viera, AJ; Parman, CL
Published in: Am Fam Physician
August 1, 2003

Selective serotonin reuptake inhibitors (SSRIs) are widely used because of their safety, tolerability, and demonstrated efficacy across a broad range of clinical conditions. Medical literature supports the use of SSRIs for the treatment of many conditions outside of the indications approved by the U.S. Food and Drug Administration. SSRIs offer a reasonable alternative to traditional therapy for generalized anxiety disorder. A side effect of SSRIs coincidentally provides therapy for premature ejaculation. SSRIs may reduce the frequency and severity of migraine headaches and are possibly effective in reducing the pain of diabetic neuropathy. When taken in combination with tricyclic antidepressants, SSRis offer more potent therapy for fibromyalgia than either agent alone. SSRIs appear to be effective in some patients with neurocardiogenic syncope that is refractory to standard therapies. Clinical experience supported by ongoing research continues to expand on the broad array of therapeutic applications for this class of medication.

Duke Scholars

Published In

Am Fam Physician

ISSN

0002-838X

Publication Date

August 1, 2003

Volume

68

Issue

3

Start / End Page

498 / 504

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Safety
  • Humans
  • General & Internal Medicine
  • Fibromyalgia
  • Drug Utilization
  • Drug Approval
  • Clinical Trials as Topic
  • Anxiety Disorders
  • Antidepressive Agents, Second-Generation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stone, K. J., Viera, A. J., & Parman, C. L. (2003). Off-label applications for SSRIs. Am Fam Physician, 68(3), 498–504.
Stone, Kimberly J., Anthony J. Viera, and Christopher L. Parman. “Off-label applications for SSRIs.Am Fam Physician 68, no. 3 (August 1, 2003): 498–504.
Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003 Aug 1;68(3):498–504.
Stone, Kimberly J., et al. “Off-label applications for SSRIs.Am Fam Physician, vol. 68, no. 3, Aug. 2003, pp. 498–504.
Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003 Aug 1;68(3):498–504.
Journal cover image

Published In

Am Fam Physician

ISSN

0002-838X

Publication Date

August 1, 2003

Volume

68

Issue

3

Start / End Page

498 / 504

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Safety
  • Humans
  • General & Internal Medicine
  • Fibromyalgia
  • Drug Utilization
  • Drug Approval
  • Clinical Trials as Topic
  • Anxiety Disorders
  • Antidepressive Agents, Second-Generation